LTFS
NVO

Ladenburg Thalmann Financial Services’s Novo Nordisk NVO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.19M Sell
76,324
-5,256
-6% -$146K 0.01% 821
2019
Q3 		$2.11M Buy
81,580
+3,518
+5% +$89K 0.01% 796
2019
Q2 		$2M Buy
78,062
+17,216
+28% +$425K 0.01% 804
2019
Q1 		$1.59M Buy
60,846
+11,346
+23% +$279K 0.01% 896
2018
Q4 		$1.14M Sell
49,500
-2,426
-5% -$53.9K 0.01% 963
2018
Q3 		$1.22M Buy
51,926
+1,134
+2% +$27.7K 0.01% 1004
2018
Q2 		$1.25M Hold
50,792
– – 0.01% 933
2018
Q1 		$1.25M Sell
50,792
-17,328
-25% -$455K 0.01% 933
2017
Q4 		$1.83M Sell
68,120
-2,618
-4% -$66.6K 0.02% 740
2017
Q3 		$1.7M Buy
70,738
+6,926
+11% +$157K 0.02% 708
2017
Q2 		$1.37M Buy
63,812
+5,424
+9% +$109K 0.02% 771
2017
Q1 		$1M Sell
58,388
-40
-0.1% -$696 0.01% 894
2016
Q4 		$1.05M Buy
58,428
+2,464
+4% +$44.7K 0.01% 827
2016
Q3 		$1.16M Sell
55,964
-1,718
-3% -$42.6K 0.02% 717
2016
Q2 		$1.55M Buy
57,682
+2,092
+4% +$57.4K 0.02% 559
2016
Q1 		$1.51M Sell
55,590
-148
-0.3% -$3.96K 0.03% 525
2015
Q4 		$1.62M Sell
55,738
-1,036
-2% -$28.7K 0.03% 483
2015
Q3 		$1.54M Sell
56,774
-25,696
-31% -$728K 0.03% 468
2015
Q2 		$2.26M Sell
82,470
-8,086
-9% -$227K 0.04% 394
2015
Q1 		$2.42M Buy
90,556
+36,284
+67% +$836K 0.05% 373
2014
Q4 		$1.15M Buy
54,272
+23,914
+79% +$534K 0.03% 540
2014
Q3 		$723K Buy
30,358
+3,392
+13% +$78.1K 0.02% 638
2014
Q2 		$623K Buy
26,966
+1,014
+4% +$22.4K 0.02% 689
2014
Q1 		$592K Buy
25,952
+1,832
+8% +$39K 0.02% 662
2013
Q4 		$446K Buy
24,120
+2,010
+9% +$35K 0.01% 730
2013
Q3 		$375K Buy
22,110
+1,870
+9% +$31.5K 0.01% 769
2013
Q2 		$317K Buy
+20,240
New +$337K 0.01% 792

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NVO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Novo Nordisk (NVO) stake by 6.4% in Q4 2019, selling an estimated $146K and leaving 76,324 shares worth $2.19M. The position accounts for 0.01% of the portfolio, ranked #821.

Ladenburg Thalmann Financial Services first reported a position in NVO in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.42M in Q1 2015. 640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 76,324 shares of Novo Nordisk worth $2.19M as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 5,256 Novo Nordisk shares in Q4 2019, an estimated $146K.
  • Novo Nordisk made up 0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #821 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Novo Nordisk in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Novo Nordisk position peaked at $2.42M in Q1 2015.
  • 640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.